SPRINGWORKS THERAPEUTICS, INC.: cashflow_financing
| Value | {"amount": 163957000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-06-30 |
| Status | current |
| Entity | SPRINGWORKS THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:59:14.073587+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3ac4c4d0-5d91-4965-895f-b51e2f02dc37
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-20-010433Retrieved: 2026-08-19T17:59:14.073587+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001773427/cashflow-financing/2019-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3ac4c4d0-5d91-4965-895f-b51e2f02dc37
History
- no predecessors — first report